Sean Smith
Keine laufenden Positionen mehr
Karriereverlauf von Sean Smith
Ehemalige bekannte Positionen von Sean Smith
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01.04.2017 | 01.08.2019 |
| NEUROGENE INC. | Comptroller/Controller/Auditor | 01.10.2019 | 31.03.2023 |
| Finanzdirektor/CFO | 31.03.2023 | - |
Ausbildung von Sean Smith
| University of North Texas | Graduate Degree |
| University of Washington | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Sean Smith
- Erfahrung
